Sara Brody is a commercial litigator and focuses her practice on securities litigation and corporate governance disputes. She is co-leader of Sidley’s Securities and Shareholder Litigation practice group and heads the Northern California litigation practice. Sara regularly defends issuers, officers, directors, underwriters and venture capital firms in shareholder class actions and derivative actions in state and federal courts throughout the United States. She also represents companies and individuals in matters involving the Securities and Exchange Commission (SEC) and various self-regulatory organizations. Sara has extensive experience in conducting internal investigations and counseling clients on disclosure issues. She routinely writes articles and lectures on a wide range of securities litigation topics in legal and business forums across the country.
Representative Matters:
- McKesson Corporation, N.D. Cal. Represents McKesson and its officers in securities class action litigation arising out of allegations of price fixing in generic drugs and in related derivative litigation.
- Flex, Ltd., N.D. Cal. Represents Flex and its officers in securities class action litigation related to its Nike relationship and automation of shoe manufacturing.
- Nektar Therapeutics, N.D. Cal. and D. Delaware. Represents Nektar and its officers and directors in securities class action and derivative litigation.
- Bloom IPO Litigation, Santa Clara Superior Court and N.D. Cal. Represents Bloom and its board in securities litigation arising out of its IPO.
- SunEdison Securities Litigation, S.D.N.Y. Lead counsel for SunEdison’s officers and directors in shareholder class actions, large individual investor actions, derivative and ERISA cases.
- Oracle Corporation, Delaware Chancery Court. Represents Oracle directors in derivative litigation in Delaware Chancery Court.
Recent SEC investigations include representations of a technology company regarding disclosure issues, a Big 4 accounting firm in connection with an investigation of revenue recognition of an audit client, a professional services firm in a multinational insider trading inquiry, an investment management company in a failed leverage bond fund, a bank’s securities lending unit in connection with an inquiry into disclosure and investment practices, the controller of a venture fund in connection with issues of disclosures and management fees, and the CEO of a public company in a matter involving allegations of financial statement manipulation.
Last updated Aug 2019
